News Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Market Closed - Nyse Other stock markets 04:00:02 2024-04-16 pm EDT			5-day change	1st Jan Change
127.4 ^USD	-0.95%		-4.02%	-7.59%

Apr. 11	John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission	CI
Apr. 05	Quest Diagnostics Receives Shareholder Proposal from John Chevedden	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission	Apr. 11	CI
Quest Diagnostics Receives Shareholder Proposal from John Chevedden	Apr. 05	CI
Ex-dividend day	Apr. 04	FA
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay	Apr. 03	AQ
Quest Collaborating With Broad Clinical Labs to Assess Whole Genome Sequencing Test for Developmental Delay Disorders	Apr. 02	MT
Quest Diagnostics - Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's disease	Mar. 27	AQ
Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease	Mar. 26	PR
Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024	Mar. 19	PR
Transcript : Quest Diagnostics Incorporated Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 10:15 AM	Mar. 13
First PFAS "Forever Chemicals" Consumer-Initiated Blood Test With Physician Consult Launches on questhealth.com	Mar. 05	AQ
Quest Diagnostics Insider Sold Shares Worth $852,769, According to a Recent SEC Filing	Mar. 01	MT
Ten Years Running: FORTUNE Names Quest Diagnostics One of 2024 "World's Most Admired Companies"	Feb. 28	AQ
Leerink Partners Starts Quest Diagnostics With Market Perform Rating, $135 Price Target	Feb. 26	MT
Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference	Feb. 23	PR
Quest Diagnostics Incorporated acquired Assets from Lenco Diagnostic Laboratories Inc. for approximately $110 million.	Feb. 21	CI
Quest Diagnostics' Pack Health, Instacart to Combine Grocery Delivery With Nutrition Coaching Services	Feb. 21	MT
The fate of the market depends on this	Feb. 21
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever....	Feb. 21
Correction: Quest Diagnostics Participates in Freenome's $254 Million Financing	Feb. 15	MT
Quest Diagnostics Participates in Freenome's $254 Million Financing	Feb. 15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Summary

Filters